Incorporating risk factors to improve the assessment of rates of glaucomatous progression

Invest Ophthalmol Vis Sci. 2012 Apr 24;53(4):2199-207. doi: 10.1167/iovs.11-8639.

Abstract

Purpose: To present and evaluate a new method of integrating risk factors into the analysis of rates of visual field progression in glaucoma.

Methods: The study included 352 eyes of 250 glaucoma patients followed up for an average of 8.1 ± 3.5 years. Slopes of change over time were evaluated by the mean deviation (MD) from standard automated perimetry. For each eye, the follow-up time was divided into two equal periods: the first half was used to obtain the slopes of change and the second period was used to test the predictions. Slopes of change were calculated with two methods: the conventional approach of ordinary least squares (OLS) linear regression and a Bayesian regression model incorporating information on risk factors and presence of progressive optic disc damage on stereophotographs. The mean square error (MSE) of the predictions was used to compare the predictive performance of the different methods.

Results: Higher mean IOP, thinner central corneal thickness (CCT), and presence of progressive optic disc damage were associated with faster rates of MD change. Incorporation of risk factor information into the calculation of individual slopes of MD change with the Bayesian method resulted in better prediction of future MD values than with the OLS method (MSE: 4.31 vs. 8.03, respectively; P < 0.001).

Conclusions: A Bayesian regression model incorporating structural and risk factor information into the estimation of glaucomatous visual field progression resulted in more accurate and precise estimates of slopes of functional change than the conventional method of OLS regression. (ClinicalTrials.gov number, NCT00221897.).

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bayes Theorem
  • Cohort Studies
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Glaucoma / diagnosis*
  • Glaucoma / physiopathology
  • Humans
  • Intraocular Pressure / physiology
  • Male
  • Middle Aged
  • Optic Disk / pathology*
  • Optic Nerve Diseases / diagnosis*
  • Optic Nerve Diseases / physiopathology
  • Risk Factors
  • Vision Disorders / diagnosis*
  • Visual Field Tests
  • Visual Fields*

Associated data

  • ClinicalTrials.gov/NCT00221897